Back to Janus Henderson Group Ltd. Janus Henderson Group Ltd.

TNGXTNGX
Showing 6 of 15 quarters

Position history for Janus Henderson Group Ltd.Janus Henderson Group Ltd.'s holdings in Tango Therapeutics, Inc.

Janus Henderson Group Ltd. holds 2.4M shares of TNGX (Tango Therapeutics, Inc.), worth $50.1M as of 2026-Q1. The position was decreased (-9.4% shares). TNGX represents 0.0% of Janus Henderson Group Ltd.'s portfolio.

Current Value

$50.1M

Current Shares

2.4M

Total Value Change

+$50M

Total Shares Change

+2.4M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Decreased
2.4M
-9.4%
$50.1M0.0%$11.50
0
2025-Q4
Increased
2.6M
+14.8%
$23.5M0.0%$8.63
33
2025-Q3
New
2.3M
-
$19.3M0.0%$8.44
39
2025-Q1
Exited
0
-100.0%
$00.0%$1.47
0
2024-Q4
Unchanged
11,631
0.0%
$35,8820.0%$3.10
0
2024-Q3
Unchanged
11,631
0.0%
$89,6170.0%$7.47
0

Other major holders of TNGX: RTW INVESTMENTS, LP, BlackRock, Inc., FMR LLC, FARALLON CAPITAL MANAGEMENT, L.L.C., GOLDMAN SACHS GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used